Tech Company Financing Transactions
Anthrogen Funding Round
On 11/12/2024, Anthrogen landed $4 million in Seed investment from BoxGroup, ReGen Ventures and private investors.
Transaction Overview
Company Name
Announced On
11/12/2024
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
800 Indiana St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Overview
From recalcitrant polymers for carbon capture, to alkane mixes for jet fuel, to alternatively branched starches for industrials, carbon backbones are everywhere. At Anthrogen we have engineered the fastest known photosynthesizing organism to ever exist on this planet. This is the basis for our unified platform of a next-generation protein foundry and enzymatic cascade technology. We engineer bacteria with CRISPR and cascade their outputs for cheap, scalable, and climate-friendly feedstock manufacturing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ankit Singhal
Chief Operating Officer
Vignesh Karthik
Chief Technical Officer
Connor Lee
Browse more venture capital transactions:
Prev: 11/12/2024: Polar Analytics venture capital transaction
Next: 11/12/2024: General Galactic venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs